Remdesivir exports banned as supply shortage hits hospitals

Seven Indian firms, including Hetero, Zydus Cadila, Cipla and DRL, make injectible Remdesivir under a licensing deal with Gilead Sciences

from mint - Science https://ift.tt/322RXZI
https://ift.tt/eA8V8J